logo
Plus   Neg
Share
Email

Reports: KKR Nears Deal To Buy Gardner Denver For More Than $75/share

Private equity firm KKR & Co. L.P. (KKR) is nearing a deal to buy industrial equipment maker Gardner Denver Inc. (GDI) for more than $75 per share, according to media reports on Monday.

In mid-February, media reports had indicated that New York-based KKR offered to acquire Gardner Denver for $75 per share, in a deal that valued the company at about $3.68 billion.

KKR's offer, which put it as a front-runner to acquire Gardner Denver, came after two other suitors reportedly walked away from the bidding process as Gardner Denver was said to be slow in assisting them with due diligence. A joint offer by Onex Corp. and TPG Capital and a separate offer from Advent International Corp. were reportedly withdrawn, partly due to lack of cooperation on part of Gardner Denver's management.

However, KKR has now reportedly increased the offer price after Gardner Denver's board sought a higher price. Gardner Denver closed Monday's trading at $73.62, valuing the company at $3.62 billion.

In late October 2012, Gardner Denver said its board was exploring strategic alternatives to enhance shareholder value, including enhancing the company's existing strategic plan or a possible sale or merger.

Bloomberg reported in early January that Gardner Denver attracted renewed interest from private equity firms KKR and Advent International Corp. after the company ended merger talks with diversified machinery company SPX Corp. (SPW).

SPX was said to have offered about $85 per share in cash and stock to buy Gardner Denver and was in exclusive talks in early December 2012 to buy the company.

In late February, Gardner Denver reported an 11 percent decline in profit for the fourth quarter on the back of lower revenues, especially in its Engineered Products Group. The company's net income for the quarter was $69.06 million or $1.40 per share, down from $77.38 million or $1.52 per share in the year-ago period. Revenue declined 4 percent to $589.67 million from $613.67 million in the same period last year.

GDI closed Monday's trading at $73.62, up $2.59 or 3.65 percent on a volume of 2.21 million shares. In after-hours, the stock further gained $0.37 or 0.50 percent to $73.99.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
RELATED NEWS
Trade GDI now with 
Follow RTT